Varaico: Literature-Extracted Genetic Variants

Gene:OTC
Variant:p.D126G
Back to variants list

OTC

NM_000531.6:p.D126G

Associated Papers

Newborn ornithine carbamyltransferase deficiency caused by new OTC gene mutations: a report of two cases and review of the literature on phenotype and genotype.

Yu A et al.

Translational Pediatrics, 2023

37969118 (PubMed )
Supplement: tp-12-10-1887-prf.pdf

Pathogenic variants of ornithine transcarbamylase deficiency: Nation-wide study in Japan and literature review.

Kido J et al.

Frontiers in Genetics, 2022

Late-Onset Ornithine Transcarbamylase Deficiency and Variable Phenotypes in Vietnamese Females With OTC Mutations.

Nguyen HH et al.

Frontiers in Pediatrics, 2020

32793520 (PubMed )
Supplement: Table_3.DOCX

Mitochondrial Enzymes of the Urea Cycle Cluster at the Inner Mitochondrial Membrane.

Haskins N et al.

Frontiers in Physiology, 2020

33551825 (PubMed )
Supplement: Data_Sheet_1.zip › SupplementaryData_DataSheet › Supplementary_Tables_S1-S6.xlsx › Table_S4

Computational pipeline to identify and characterize functional mutations in ornithine transcarbamylase deficiency.

Magesh R et al.

3 Biotech, 2014

1.85-A resolution crystal structure of human ornithine transcarbamoylase complexed with N-phosphonacetyl-L-ornithine. Catalytic mechanism and correlation with inherited deficiency.

Shi D et al.

The Journal of Biological Chemistry, 1998

Prenatal diagnosis of ornithine transcarbamylase deficiency by using a single nucleated erythrocyte from maternal blood.

Watanabe A et al.

Human Genetics, 1998

Ten novel mutations of the ornithine transcarbamylase (OTC) gene in OTC deficiency.

Shimadzu M et al.

Human Mutation, 1998

The biochemical and molecular spectrum of ornithine transcarbamylase deficiency.

Tuchman M et al.

Journal of Inherited Metabolic Disease, 1998

The ornithine transcarbamylase (OTC) gene: mutations in 50 Japanese families with OTC deficiency.

Matsuda I et al.

American Journal of Medical Genetics, 1997

Prenatal monitoring in a family at high risk for ornithine transcarbamylase (OTC) deficiency: a new mutation of an A-to-C transversion in position +4 of intron 1 of the OTC gene that is likely to abolish enzyme activity.

Hoshide R et al.

American Journal of Medical Genetics, 1996

Identification of four novel splice site mutations in the ornithine transcarbamylase gene.

Oppliger Leibundgut E et al.

Human Genetics, 1996

[Gene therapy for ornithine transcarbamylase deficiency].

Matsuda I et al.

Tanpakushitsu Kakusan Koso. Protein, Nucleic Acid, Enzyme, 1995

A splicing mutation, a nonsense mutation (Y167X) and two missense mutations (I159T and A209V) in Spanish patients with ornithine transcarbamylase deficiency.

García-Pérez MA et al.

Human Genetics, 1995

The molecular basis of ornithine transcarbamylase deficiency: modelling the human enzyme and the effects of mutations.

Tuchman M et al.

Journal of Medical Genetics, 1995

Four newly identified ornithine transcarbamylase (OTC) mutations (D126G, R129H, I172M and W332X) in Japanese male patients with early-onset OTC deficiency.

Matsuura T et al.

Human Mutation, 1994

[A case of ornithine transcarbamylase deficiency associated with acute left hemiplegia].

Hasegawa K et al.

No to Hattatsu = Brain and Development, 1988

Select a paper to view details
UCSC Genome Browser·Imprint·Privacy·Terms·Feedback·Email Updates·

Regarding the variants extracted from papers and shown text snippets from research papers, the following holds: "Some rights reserved. This work permits non-commercial use, distribution and reproduction in any medium, provided the original author and source are credited."